Optimization of a heterologous mevalonate pathway through the use of variant HMG-CoA reductases.
Ma SM, Garcia DE, Redding-Johanson AM, Friedland GD, Chan R, Batth TS, Haliburton JR, Chivian D, Keasling JD, Petzold CJ, Lee TS, Chhabra SR.
Ma SM, et al. Among authors: lee ts.
Metab Eng. 2011 Sep;13(5):588-97. doi: 10.1016/j.ymben.2011.07.001. Epub 2011 Jul 28.
Metab Eng. 2011.
PMID: 21810477